Skip to main content

Advertisement

SpringerLink
Log in

Neuron Specific Enolase and C-reactive Protein Levels in Stroke and Its Subtypes: Correlation with Degree of Disability

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Stroke is an emergency which threatens life and third leading cause of death and long term disability in developed countries. The use of biomarkers in diagnosing stroke and assessing prognosis is an emerging and rapidly evolving field. The study aimed to investigate the predictive value of biochemical marker of brain damage neuron-specific enolase (NSE) and systemic inflammatory marker C-reactive protein (CRP) with respect to degree of disability at the time of admission and short term in stroke patients. We investigated 120 patients with cerebrovascular stroke who were admitted within 72 h of onset of stroke in the Department of Neurology at Sri Aurobindo Institute of Medical Sciences, Indore, India. NSE and CRP were analyzed by solid enzyme linked immunosorbent assay using analyzer and micro plate reader from Biorad 680. In all patients, the neurological status was evaluated by a standardized neurological examination and the National Institutes of Health Stroke Scale on admission and on day 7. Serum NSE and CRP concentration were found significantly increased in acute stroke cases as compared to control in present study (<0.05 and <0.001 respectively). The maximum serum NSE and CRP levels within 72 h of admission were significantly higher in patients with greater degree of disability at the time of admission. Both biomarkers were found significantly correlated with neurological disability and short term outcome. Our study showed that serum biomarkers NSE and CRP have high predictive value for determining severity and early neurobehavioral outcome after acute stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kim MH, Kang SY, Kim MC, Lee WI (2010) Plasma biomarkers in the diagnosis of acute ischemic stroke. Ann Clin Lab Sci 40:336–341

    CAS  PubMed  Google Scholar 

  2. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al (2011) Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:227–276

    Article  PubMed  Google Scholar 

  3. Steinwachs DM, Collins-Nakai RL, Cohn LH, Garson A Jr, Wolk MJ (2000) The future of cardiology: utilization and costs of care. J Am Coll Cardiol 35:1092–1099

    Article  CAS  PubMed  Google Scholar 

  4. Mathers CD, Lopez AD, Murray CJL (2006) The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M et al (eds) Global burden of disease and risk factors. World Bank, Washington

    Google Scholar 

  5. Cunningham RT, Young IS, Winder J, O’Kane MJ, McKinstry S, Johnston CF et al (1991) Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 21:497–500

    Article  CAS  PubMed  Google Scholar 

  6. Hardemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y et al (1989) S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 71:727–731

    Article  CAS  PubMed  Google Scholar 

  7. Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther 9:1565–1584

    Article  PubMed  Google Scholar 

  8. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843

    Article  CAS  PubMed  Google Scholar 

  9. Ridker PM (2000) Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation 105:2583–2585

    Article  Google Scholar 

  10. Kwan J, Hand P (2006) Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM 99:625–633

    Article  CAS  PubMed  Google Scholar 

  11. Feigin V, Lawes C, Bennet D, Barker Cello S, Parag V (2009) Worldwide stroke incidence and early case fatality in 56 population based studies: a systematic review. Lancet Neurol 8:355–369

    Article  PubMed  Google Scholar 

  12. Pandian J, Jaison A, Deepak SS, Kalra G, Shamsher S, Lincoln DJ et al (2005) Public awareness of warning symptoms, risk factors and treatment of stroke in Northwest India. Stroke 36:644–648

    Article  PubMed  Google Scholar 

  13. Sethi P (2002) Stroke-incidence in India and management of ischaemic stroke. Neurosciences 4:139–141

    Google Scholar 

  14. Das S, Banerjee T (2008) Stroke Indian scenario. Circulation 118:2719–2724

    Article  PubMed  Google Scholar 

  15. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC et al (1999) Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 30:1528–1533

    Article  CAS  PubMed  Google Scholar 

  16. Kaca-Oryńska M, Tomasiuk R, Friedman A (2010) Neuron-specific enolase and S 100B protein as predictors of outcome in ischaemic stroke. Neurol Neurochir Pol 44:459–463

    PubMed  Google Scholar 

  17. Selakovic V, Raicevic R, Radenovic L (2005) The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 12:542–547

    Article  CAS  PubMed  Google Scholar 

  18. Pandey A, Saxena K, Verma M, Bharosay A (2011) Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients. J Neurosci Rural Pract 2:50–54

    Article  PubMed Central  PubMed  Google Scholar 

  19. Brea D, Sobrino T, Blanco M, Cristobo I, Rodríguez-González R, Rodríguez-Yañez M et al (2009) Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 47:1513–1518

    Article  CAS  PubMed  Google Scholar 

  20. Dwi Lily L, Endang Retnowati K (2007) Role of serum neuron specific enolase (NSE) to differentiate ischemic stroke from hemorrhagic stroke and its correlation with brain damage volume. Folia Med Indones 43:230–234

    Google Scholar 

  21. Klaus KA, Olsen TS, Dehlendorff C, Kammersgaard LP (2009) Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 40:2068–2072

    Article  Google Scholar 

  22. Bharosay A, Bharosay VV, Varma M, Saxena K, Sodani A, Saxena R (2012) Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Indian J Clin Biochem 27:186–190

    Article  PubMed Central  PubMed  Google Scholar 

  23. Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M et al (1997) Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 148:101–105

    Article  CAS  PubMed  Google Scholar 

  24. Missler U, Wiesmann M, Friedrich C, Kaps M (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956–1960

    Article  CAS  PubMed  Google Scholar 

  25. Bharosay A, Saxena K, Varma M, Bharosay VV, Pandey A (2011) Correlation between proinflammatory serum markers: high sensitivity C-reactive protein, interleukin-6 with disability score in acute ischemic stroke. Indian J Clin Biochem 26:279–282

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Di Napoli M, Papa F, Bocola V (2001) Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32:133–138

    Article  PubMed  Google Scholar 

  27. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36:1316–1329

    Article  PubMed  Google Scholar 

  28. Eikelboom JW, Hankey GJ, Baker RI, McQuillan A, Thom J, Staton J et al (2003) C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 12:74–81

    Article  PubMed  Google Scholar 

  29. Mishra PT, Chandra R, Saxena SK, Verma S, Jain R, Bhuyan A (2010) High sensitivity C-reactive protein (hsCRP) level in cerebrovascular accident (stroke). JIACM 11:204–207

    Google Scholar 

  30. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J et al (2005) C reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population. Stroke 37:27–32

    Article  PubMed  Google Scholar 

  31. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL (2006) High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and outcome after ischemic stroke. Arch Intern Med 166:2073–2080

    Article  CAS  PubMed  Google Scholar 

  32. Kumar SS, Grant PJ, Catto AJ, Bamford JM, Carter A (2009) Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke 40:977–979

    Article  Google Scholar 

  33. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P (2006) Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37:2018–2023

    Article  CAS  PubMed  Google Scholar 

  34. Audebert HJ, Rott MM, Eck T, Haberl RL (2004) Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128–2133

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Narshinbhai Patel Dental College and Hospital, Visnagar, India

    Aparna Pandey

  2. Department of Biochemistry, Sudha Rustagi College of Dental Sciences and Research, Kheri More, Faridabad, 121002, India

    Amit Kumar Shrivastava

  3. Department of Biochemistry, Chirayu Medical College and Hospital, Bhopal, India

    Kiran Saxena

Authors
  1. Aparna Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amit Kumar Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kiran Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Kumar Shrivastava.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pandey, A., Shrivastava, A.K. & Saxena, K. Neuron Specific Enolase and C-reactive Protein Levels in Stroke and Its Subtypes: Correlation with Degree of Disability. Neurochem Res 39, 1426–1432 (2014). https://doi.org/10.1007/s11064-014-1328-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-014-1328-9

Keywords

Search

Navigation